Assessing Turning Point Brands (NYSE:TPB) Valuation After Modern Oral Growth And Raised Sales Guidance

Simply Wall St.

May 12

Turning Point Brands (TPB) is back in focus after first quarter 2026 results, where Modern Oral revenue growth and a raise to full year sales guidance stood out against mixed performance in other ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2634298620"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2634298620\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2634298620?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/5131000-choice2-main-header/1585186906815","is_english":true,"pubTime":"2026-05-12 14:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634298620","market":"us","top_or_hot":-1,"title":"Assessing Turning Point Brands (NYSE:TPB) Valuation After Modern Oral Growth And Raised Sales Guidance","media":"Simply Wall St.","content":"<div>\n<p>Turning Point Brands (TPB) is back in focus after first quarter 2026 results, where Modern Oral revenue growth and a raise to full year sales guidance stood out against mixed performance in other ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tpb/turning-point-brands/news/assessing-turning-point-brands-nysetpb-valuation-after-moder\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Assessing Turning Point Brands (NYSE:TPB) Valuation After Modern Oral Growth And Raised Sales Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAssessing Turning Point Brands (NYSE:TPB) Valuation After Modern Oral Growth And Raised Sales Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-05-12 14:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tpb/turning-point-brands/news/assessing-turning-point-brands-nysetpb-valuation-after-moder><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Turning Point Brands (TPB) is back in focus after first quarter 2026 results, where Modern Oral revenue growth and a raise to full year sales guidance stood out against mixed performance in other ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tpb/turning-point-brands/news/assessing-turning-point-brands-nysetpb-valuation-after-moder\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TPB","symbol_name":"Turning Point Brands Inc.","start_time":0,"source_url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tpb/turning-point-brands/news/assessing-turning-point-brands-nysetpb-valuation-after-moder","article_id":"2634298620","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/5131000-choice2-main-header/1585186906815"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tpb/turning-point-brands/news/assessing-turning-point-brands-nysetpb-valuation-after-moder","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2634298620","pubTimestamp":1778567480,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Turning Point Brands (TPB) is back in focus after first quarter 2026 results, where Modern Oral revenue growth and a raise to full year sales guidance stood out against mixed performance in other segments.\nSee our latest analysis for Turning Point Brands.\nAt a share price of $92.71, Turning Point Brands has seen a 7 day share price return of 13.53% and a 30 day share price return of 10.95%. However, the 90 day share price return is down 27.26%, while the 1 year total shareholder return of...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"TPB":"Turning Point Brands Inc.","NYSE":"纽交所"},"translate_title":"在现代口腔增长和提高销售指导后评估Turning Point Brands(NYSE：TPB)的估值","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TPB":1.5,"NYSE":1.5},"content_text":"Turning Point Brands (TPB) is back in focus after first quarter 2026 results, where Modern Oral revenue growth and a raise to full year sales guidance stood out against mixed performance in other segments. See our latest analysis for Turning Point Brands. At a share price of $92.71, Turning Point Brands has seen a 7 day share price return of 13.53% and a 30 day share price return of 10.95%. However, the 90 day share price return is down 27.26%, while the 1 year total shareholder return of 32.95% and very large 3 year total shareholder return indicate longer term momentum that contrasts with the recent pullback. If you are looking beyond tobacco and oral nicotine, this could be a useful moment to broaden your watchlist with 19 top founder-led companies With Modern Oral growth, raised sales guidance, a very large long-term total return, and a recent 90-day pullback, is TPB still undervalued or is the market already pricing in future growth? AdvertisementMost Popular Narrative: 30% Undervalued With the current share price at $92.71 versus a narrative fair value of $132.50, the gap between market price and modeled value is wide enough to catch attention and worth unpacking further.  Strong growth in the Modern Oral nicotine pouch segment, with sales growing nearly 8x year-over-year and now accounting for 26% of total revenue, positions TPB to capture significant market share in a category projected to reach $10 billion by decade's end; this will drive long-term revenue and margin expansion as the modern oral segment scales and premiumizes.  Read the complete narrative. Want to see what sits behind that bold Modern Oral claim? The narrative leans on brisk revenue expansion, shifting margins and a richer earnings multiple than the broader tobacco sector. Curious which specific assumptions have to line up for that fair value to hold up? Result: Fair Value of $132.50 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, the story could change quickly if Modern Oral growth underwhelms after higher trade spend, or if new regulation hits nicotine pouches harder than analysts expect. Find out about the key risks to this Turning Point Brands narrative. Another View: Multiples Paint a Tougher Picture While the narrative fair value points to upside, the current P/E of 32.4x sits above both peers at 28.9x and the global tobacco average at 12.5x, and is roughly in line with the 32.3x fair ratio. That leaves less obvious cushion if modern oral growth or margins fall short. It is worth asking whether you are comfortable paying a richer multiple today, or if you would rather wait for either earnings to catch up or the price to reset before taking a view on TPB's long term narrative. See what the numbers say about this price — find out in our valuation breakdown. NYSE:TPB P/E Ratio as at May 2026Next Steps Mixed signals on valuation so far? For a clearer picture, look through the data yourself and weigh both sides of the story with 3 key rewards and 1 important warning sign Looking for more investment ideas? If TPB is already on your radar, do not stop there. Use this moment to widen your opportunity set with data driven stock ideas tailored to different goals.  Target potential mispricings by scanning a focused list of 47 high quality undervalued stocks that combine quality fundamentals with compressed expectations. Strengthen income potential by reviewing 12 dividend fortresses that pair higher yields with balance sheets designed to support ongoing distributions. Protect your downside first by filtering for 70 resilient stocks with low risk scores where business quality and risk scores work together to limit unpleasant surprises.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Turning Point Brands might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}